openPR Logo
Press release

Hospital Infectious Disease Testing Market Research Report : Major Factors & Applications 2024

07-31-2017 03:18 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Hospital Infectious Disease Testing Market Research Report :

Hospital infectious disease testing is a procedure to identify hospital acquired/related infections. Hospital infections are among the most prominent challenges faced by health care delivery systems across the globe. Hospital infectious diseases are considered a significant cause of death globally. These are acquired while receiving health care treatment. Hospital infectious diseases tests are performed by health care professionals, especially clinical laboratory technicians, for the diagnosis of infections.

Read the Comprehensive Overview of Hospital Infectious Disease Testing Market: http://www.transparencymarketresearch.com/hospital-infectious-disease-testing-market.html

Based on test type, the global hospital infectious disease testing market has been broadly segmented into:

Urinary tract infection (UTI)
Surgical site Infection
Pneumonia
Bloodstream infection
MRSA
Others

The UTI segment accounted for the major share of the hospital infectious disease testing market, followed by surgical site infections and pneumonia. Hospital infectious diseases are required to be closely monitored due to increase in antimicrobial resistance in some regions. Automated urine microscopy is the most preferred diagnostic tool adopted by clinical technicians for UTI. Prevalence of pneumonia and deaths associated with it are increasing gradually. Other hospital infections include cardiovascular, systemic, joint and bone, respiratory, and ENT (enteric) infections.

The hospital infectious disease testing market has experienced strong growth in the last decade due to factors such as increased awareness about growth in the incidence of infections globally and development of innovative prevention and treatment solutions. Major factors driving the market are establishment of quality government guidelines and uniform code for prevention of hospital infectious diseases. Lack of funding and skilled manpower in developing countries and lack of stringent guidelines and framework to control the morbidity rate of hospital infections are restraining the hospital infectious disease testing market. Lack of controlling authorities and controlling programs in lesser developed regions is another major factor hampering market growth. Technological development of molecular diagnostics and passage of the Patient Care and Affordable Care Act in the U.S. are likely to offer significant opportunities in the market in the near future.

Geographically, the global hospital infectious disease testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the market due to growing patient awareness, favorable initiatives taken by the federal government, and large number of market players based in the region. The hospital infectious disease testing market in Europe is mature due to presence of strong and active hospital infection control and prevention authorities and guidelines such as the NHS in the U.K. Moreover, Europe is considered the hub for the global geriatric population. It is observed that geriatrics are more prone to various infections. This is likely to increase demand in Europe. Asia Pacific is a lucrative market for hospital infectious disease testing products as the overall prevalence of the infections in this region is high. Moreover, stringent guidelines have been set for the prevention and control of such conditions in the health care infrastructure in this region. Countries such as China, India, Japan, Thailand, Australia, and the Philippines are expected to be the major contributors to the hospital infectious disease testing market in Asia Pacific. Latin America and Middle East & Africa are considered the emerging markets for hospital infectious disease testing. This is attributed to increasing investment by governments for effective health care infrastructure in the region.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20612

Key players operating in the hospital infectious disease testing market include Abbott Laboratories, Alere, Inc., Thermo Fisher Scientific, Inc. (Life Technologies Corporation), Becton, Dickinson and Company, bioMérieux SA, F. Hoffmann-La Roche Ltd., Hologic, Inc., Siemens Healthineers, Diatherix Laboratories, Inc., Meridian Bioscience, Inc., Cepheid, Inc., and QIAGEN.

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hospital Infectious Disease Testing Market Research Report : Major Factors & Applications 2024 here

News-ID: 648854 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Hospital

Outbound Medical Tourism Services Market 2021-2027| Christus Muguerza Hospital, …
Outbound Medical Tourism Services refers to people traveling abroad to obtain medical treatment. An informative data report titled Outbound Medical Tourism Services Market was published by Reportsweb. It takes a closer look at the different aspects of the businesses, that are responsible for fuelling the growth of the companies. Additionally, it offers some significant factors, which are restraining the progress of the industries. To predict the turning point of the businesses,
Canada Hospital Supplies Market Report - Disposable Hospital Supplies, Hospital …
ReportsnReports added a new report on The Canada Hospital Supplies Market report that delivers the clean elaborated structure of the Report comprising each and every business-related information of the market at a global level. The in-depth study on the current state which focuses on the major drivers and restraints for the key players. Canada Hospital Supplies Market Industry research report provides granular analysis of the market share, segmentation, revenue forecasts,
Veterinary Orthopedic Treatment Market Key Players| Adobe Animal Hospital, Allan …
A Comprehensive research study conducted by KD Market Insights on " Veterinary Orthopedic Treatment Market by Procedure (Cruciate Ligament Tear, Patellar Luxation, Hip Dysplasia, Elbow Dysplasia, Bone Fracture, and Osteoarthritis Management), and Animal Type (Dog, Cat and Other Animal Types): Global Opportunity Analysis and Industry Forecast, 2017 - 2025" report offers extensive and highly detailed historical, current and future market trends in the global and regional/market. The Veterinary Orthopedic Treatment Market report includes market size,
Hospital Profitability Market SWOT Analysis of Key Players- Mayo Clinic Hospital …
HTF MI has added the report on Global Hospital Profitability Market for the forecast till 2025, the report comprises of the estimation of the Global Hospital Profitability Market. The following Industry is shown to progress with a noteworthy rise in the Compound Annual Growth Rate (CAGR) during the forecast period owing to various factors driving the market. Some of the key players mentioned in this research are "Mayo Clinic Hospital,
Medical Tourism Market Key Players- Bumrungrad International Hospital, Bangkok C …
As per the current market trends and the promising nature of the “Global Medical Tourism Market” market, it can be estimated that the future holds positive outcomes. In order to provide a deep insight about the concerned market, Market Research Reports Search Engine would be publishing a resourceful analysis that will enclose knowledge about the regional market size, revenue and opportunity status. Readers will be offered the privilege to decode
Hospital Profitability Market - Mayo Clinic Hospital, The Cleveland Clinic, The …
Global Hospital Profitability Market Size, Status and Forecast 2022 provides Market information about top Key Players, Countries, Type and Application. This Industry report also states Company Profile, sales, Hospital Profitability Market revenue and price, market share, market growth and gross margin by regions. Top Key Players: Mayo Clinic Hospital The Cleveland Clinic The Jhons Hopkins Hospital Massachusetts General Hospital Ronald Reagan UCLA Medical Center Peking Union Medical College Hospital West China Hospital of Sichuan University Chinese PLA General